Axcelis Tech Ord Stock Price, News & Analysis

Axcelis Technologies (NASDAQ: ACLS) will participate in the 11th Annual NYC Summit on December 13, 2022, in New York City. The event features small group meetings between investors and company management teams. Presentation materials will be accessible on Axcelis' investor page. The NYC Summit is invitation-only for accredited investors and research analysts, with RSVP required by December 1, 2022. Axcelis has a strong track record in providing ion implantation solutions for the semiconductor industry, serving the market for over 40 years.

On Nov. 17, 2022, Axcelis Technologies (Nasdaq: ACLS) announced its founding membership in the Semiconductor Climate Consortium (SCC), aimed at combating climate change within the semiconductor industry. President and CEO Mary Puma emphasized this membership enhances Axcelis' sustainability efforts through collaboration. The SCC focuses on pooling industry resources to tackle decarbonization challenges and sets collective sustainability goals. Axcelis has over 40 years of experience in providing innovative ion implantation solutions critical to integrated circuit manufacturing.

On November 10, 2022, Axcelis Technologies (Nasdaq: ACLS) announced significant new shipments of its Purion Power Series ion implanter systems to various fabs in Asia and Europe. This includes the first SiC tool shipped from their South Korea operations. Key models shipped are the Purion H200, Purion XE, and Purion M, aimed at high-volume production of Si and SiC power devices. CEO Mary Puma highlighted continued growth in the power device market and emphasized the company's technological advantages and market share prospects.

Axcelis Technologies reported a strong financial performance in Q3 2022, with revenue of $229.2 million, up from $221.2 million in Q2. Operating profit decreased slightly to $53.2 million, while net income was $40.3 million, or $1.21 per diluted share, down from $44.2 million or $1.32 per diluted share. Gross margin improved to 45.1%. The company also reported a record systems backlog of $1.1 billion and booking of $337.1 million. For Q4 2022, Axcelis expects revenue of $232-240 million and operating profit of $41-45 million.

Axcelis Technologies (Nasdaq: ACLS) announced shipments of its PurionH™ and PurionXE™ implanters to a major analog chip manufacturer in North America. This follows a series of multi-year purchase orders aimed at enhancing the chipmaker's manufacturing capabilities. CEO Mary Puma highlighted the customer's confidence in Axcelis, reflecting strong business relationships.

The company has over 40 years of experience in the semiconductor sector, focusing on high-productivity solutions and support for critical ion implantation processes.

Axcelis Technologies (Nasdaq: ACLS) will release its third quarter 2022 financial results on November 2, 2022, at 4:00 p.m. ET. A follow-up conference call to discuss the results is scheduled for November 3, 2022, at 8:30 a.m. ET. Interested parties can access the call via an audio webcast on the company's website. The company specializes in high-productivity solutions for the semiconductor industry, particularly in the area of ion implantation systems.

Axcelis Technologies, Inc. (NASDAQ: ACLS) announced the qualification of its Purion XEmax high energy ion implant system for production at a leading CMOS image sensor manufacturer. This advancement is expected to enhance image sensor technology and production capabilities, driving growth in the image sensor market. The Purion XEmax is designed for high-performance applications, featuring advanced filtration systems to maintain photodiode quality. This move reflects Axcelis’ commitment to innovation in semiconductor solutions amid increasing demand.

Axcelis Technologies (NASDAQ: ACLS) announced its sponsorship and participation in the International Conference on Ion Implantation Technology 2022, set for September 25-29 in San Diego, CA. This marks over 40 years of Axcelis's involvement in the conference series. The event will focus on advances in ion implantation technologies, featuring presentations on topics such as the Purion H200™ single wafer implanter and advanced angle control solutions. Axcelis aims to address critical challenges in the semiconductor industry through these discussions.